Urology

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Wanda Filer, MD, MBA FAAFP, from Pelvital, discusses how the Flyte device uses groundbreaking mechanotherapy to provide an effective, non-surgical solution for stress urinary incontinence.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A survey by Aeroflow Urology finds many mothers face postpartum incontinence without medical support, impacting their health, stress, and daily life.

BlueWind Medical’s Revi System shows strong two-year efficacy and safety for UUI, with symptom reduction and high patient satisfaction.

A new study demonstrates the efficacy of a deep learning-based transperineal ultrasound system for evaluating bladder neck motion in women with stress urinary incontinence.

A recent study found a sharp rise in Medicare claims for multiplex urinary tract infection testing from 2016 to 2023, underscoring a significant financial impact and the need for further research into its clinical benefits.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A study highlights the poor quality of online information about urinary tract infections and asymptomatic bacteriuria, raising concerns about inaccurate diagnoses, overtreatment, and antibiotic resistance.

Iterum Therapeutics has announced the FDA has approved ORLYNVAH (sulopenem etzadroxil and probenecid) for the treatment of uncomplicated urinary tract infections (uUTIs)

In a recent study, significantly more urology websites contained information about male sexual dysfunction when compared to the availability of female sexual dysfunction information on ob-gyn websites.

In a recent study presented at the 25th Annual Fall Scientific Meeting of SMSNA, similar diagnosing success was reported between self-diagnosis and diagnosis from a health care provider for vaginismus.

In a recent study, women with urinary incontinence were more likely to experience postpartum depression at both under and over 6 months after delivery.

The advisory committee meeting will discuss the potential approval of oral sulopenem etzadroxil/probenecid tablets for treating urinary tract infections in women aged 18 years and older.

A new pilot study published in the International Urogynecology Journal found that Materna Medical’s Prep Device, a pelvic floor dilator, reduced full levator ani muscle avulsion during vaginal delivery in first-time mothers.

A study found that both synthetic and nonsynthetic slings show similar success rates for treating stress urinary incontinence in women, with synthetic slings demonstrating improved operative outcomes and reduced complications.

The third and final episode in our series looks at what is in the pipeline as well as a discussion around FDA guidance.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

The second episode in our series looks to address clinical management in a time when antimicrobial resistance appears to be growing.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

This series looks to discuss several topics around these infections including diagnosis, treatment, challenges in managing UTIs in patients with dementia and neurogenic bladders, antibiotic resistance, and considerations for patients and caregiver engagement.

A recent study found that urinary incontinence does not impact cognitive performance in individuals aged under 70 years old.

Mubashir S. Billah, MD, discusses a study presented at the 2024 AUA Annual Meeting, which evaluates the efficacy of AI-generated summaries against traditional human-written summaries in the field of incontinence research.

A recent study reveals that daily d-mannose supplementation does not reduce the incidence of recurrent urinary tract infections in women.